发明名称 FLAP MODULATORS
摘要 The present invention relates to compounds of Formula (I),;;or a form thereof, wherein ring A, R1, R2, R3, R3′, L, W, and V are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention
申请公布号 US2015259357(A1) 申请公布日期 2015.09.17
申请号 US201514728128 申请日期 2015.06.02
申请人 JANSSEN PHARMACEUTICA NV 发明人 Bacani Genesis M.;Eccles Wendy;Fitzgerald Anne E.;Goldberg Steven D.;Hack Michael D.;Hawryluk Natalie A.;Jones William M.;Keith John M.;Krawczuk Paul;Lebsack Alec D.;Lee-Dutra Alice;Liu Jing;McClure Kelly J.;Meduna Steven P.;Pippel Daniel J.;Rosen Mark D.;Sales Zachary S.
分类号 C07D498/04;C07D487/04;C07D471/04 主分类号 C07D498/04
代理机构 代理人
主权项 1. A compound of Formula (I)wherein L is a bond, —CH2—, —SO2—, —CH2—SO2—, —SO2—CH2—, —SO2—NR—, —SO2—NR—CH2—, —CH2—SO2—NR—, —NR—, —NR—SO2—, —S—, —S—CH2—, —CH2—S—, —C(═O)—, —O—, —O—CH2—, —NR—C(═O)—, or —C(═O)—NR—, wherein R is H, C1-2alkyl, C1-2alkyl-OH or cyclopropyl; R1 is H, halo, methyl, CF3, —O—CF3, or —O—CH3; R2 is H, cyano, halo, 2-(trimethylsilyl)ethoxy, phenyl, C1-6alkyl, heteroaryl, heterocyclyl, C3-9cycloalkyl, provided R2 is not H if L is a bond, and wherein said phenyl, C1-6alkyl, heteroaryl, heterocyclyl or C3-9cycloalkyl is optionally and independently substituted selected from the group consisting of: methyl, ethyl, oxo, fluoro, hydroxyl, cyano, amino, methoxy, tert-butoxy, acetyl, cyclopropyl, cyclobutyl, cyclohexyl, phenyl, azetidin-1-yl, azetidin-3-yl, pyrrolidin-1-yl, 2,4-dihydro-3H-1,2,4-triazol-3-one-4-yl, 1H-imidazol-4-yl, pyrazin-2-yl, pyrimidin-2-yl, 1,3-oxazolidin-2-one-5-yl, N-benzamide, 4-methylpiperazin-1-yl, morpholin-4-yl, CF3, —SO2—CH3, —C(═O)-cyclopropyl, —NHCH3, —N(CH3)2, —NHAc, —NHCO2t-Bu, —CH2—NH2, —C(═O)—NH2, —C(═O)—N(ethyl)2, —NH—C(═O)—NH2, —NH—C(═O)—CH3, —C(═O)—(C1-C4alkyl), —C(═O)—OH, —C(═O)—NH(C1-C4alkyl)-(CH2)n—OH, and —(CH2)n—CN, wherein n is 1 or 2; V is CH, CR′, or N, wherein R′ is methyl or F; W is CR″ or N, wherein R″ is H, F, hydroxyl, amino, CH3 or —O—CH3; ring A is selected from the group consisting of: R3 is H, F, methyl, or —O—CH3; R3′ is H or F; R4 is H, methyl, cyano, amino, halo, —COOH, or —O—CH3; R5 is H, methyl, cyano, or —CF3; R6 is H, cyano, amino, halo, or —CF3; and R7 is halo, amino, —CONH2, cyano, —O—CH3, —CF3, or —COO-ethyl;or a pharmaceutically acceptable salt thereof.
地址 Beerse BE